nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—CHRM3—Carbachol—glaucoma	0.129	0.183	CbGbCtD
Scopolamine—CHRM3—Pilocarpine—glaucoma	0.12	0.17	CbGbCtD
Scopolamine—CHRM1—Carbachol—glaucoma	0.112	0.159	CbGbCtD
Scopolamine—CHRM1—Pilocarpine—glaucoma	0.104	0.148	CbGbCtD
Scopolamine—CHRM2—Carbachol—glaucoma	0.103	0.147	CbGbCtD
Scopolamine—CHRM2—Pilocarpine—glaucoma	0.096	0.137	CbGbCtD
Scopolamine—ABCB1—Timolol—glaucoma	0.0213	0.0303	CbGbCtD
Scopolamine—ABCB1—Clonidine—glaucoma	0.0181	0.0258	CbGbCtD
Scopolamine—Tremor—Pilocarpine—glaucoma	0.000299	0.00107	CcSEcCtD
Scopolamine—Somnolence—Apraclonidine—glaucoma	0.000299	0.00107	CcSEcCtD
Scopolamine—Vertigo—Brinzolamide—glaucoma	0.000299	0.00107	CcSEcCtD
Scopolamine—Bradycardia—Clonidine—glaucoma	0.000298	0.00106	CcSEcCtD
Scopolamine—Dysuria—Betaxolol—glaucoma	0.000298	0.00106	CcSEcCtD
Scopolamine—Pruritus—Latanoprost—glaucoma	0.000298	0.00106	CcSEcCtD
Scopolamine—Rash—Diclofenamide—glaucoma	0.000298	0.00106	CcSEcCtD
Scopolamine—Headache—Diclofenamide—glaucoma	0.000296	0.00106	CcSEcCtD
Scopolamine—Dry mouth—Brimonidine—glaucoma	0.000295	0.00105	CcSEcCtD
Scopolamine—Agitation—Pilocarpine—glaucoma	0.000294	0.00105	CcSEcCtD
Scopolamine—Vomiting—Carbachol—glaucoma	0.000293	0.00105	CcSEcCtD
Scopolamine—Hallucination—Clonidine—glaucoma	0.000292	0.00104	CcSEcCtD
Scopolamine—Rash—Carbachol—glaucoma	0.000291	0.00104	CcSEcCtD
Scopolamine—Dermatitis—Carbachol—glaucoma	0.00029	0.00104	CcSEcCtD
Scopolamine—Fatigue—Apraclonidine—glaucoma	0.00029	0.00104	CcSEcCtD
Scopolamine—Somnolence—Bimatoprost—glaucoma	0.00029	0.00104	CcSEcCtD
Scopolamine—Oedema—Brimonidine—glaucoma	0.000289	0.00103	CcSEcCtD
Scopolamine—Headache—Carbachol—glaucoma	0.000289	0.00103	CcSEcCtD
Scopolamine—Constipation—Apraclonidine—glaucoma	0.000288	0.00103	CcSEcCtD
Scopolamine—Pain—Apraclonidine—glaucoma	0.000288	0.00103	CcSEcCtD
Scopolamine—Nausea—Carteolol—glaucoma	0.000285	0.00102	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000285	0.00102	CcSEcCtD
Scopolamine—Headache—Levobunolol—glaucoma	0.000284	0.00101	CcSEcCtD
Scopolamine—Nervous system disorder—Brimonidine—glaucoma	0.000283	0.00101	CcSEcCtD
Scopolamine—Tachycardia—Brimonidine—glaucoma	0.000282	0.00101	CcSEcCtD
Scopolamine—Dry mouth—Dorzolamide—glaucoma	0.000281	0.001	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000281	0.001	CcSEcCtD
Scopolamine—Skin disorder—Brimonidine—glaucoma	0.000281	0.001	CcSEcCtD
Scopolamine—Nausea—Diclofenamide—glaucoma	0.000281	0.001	CcSEcCtD
Scopolamine—Dry mouth—Travoprost—glaucoma	0.00028	0.001	CcSEcCtD
Scopolamine—Pain—Bimatoprost—glaucoma	0.000279	0.000996	CcSEcCtD
Scopolamine—Dizziness—Latanoprost—glaucoma	0.000278	0.000993	CcSEcCtD
Scopolamine—Confusional state—Dorzolamide—glaucoma	0.000278	0.000993	CcSEcCtD
Scopolamine—Feeling abnormal—Apraclonidine—glaucoma	0.000277	0.00099	CcSEcCtD
Scopolamine—Dry mouth—Brinzolamide—glaucoma	0.000277	0.000988	CcSEcCtD
Scopolamine—Vomiting—Methazolamide—glaucoma	0.000276	0.000987	CcSEcCtD
Scopolamine—Conjunctivitis—Betaxolol—glaucoma	0.000276	0.000986	CcSEcCtD
Scopolamine—Oedema—Dorzolamide—glaucoma	0.000276	0.000985	CcSEcCtD
Scopolamine—Oedema—Travoprost—glaucoma	0.000275	0.00098	CcSEcCtD
Scopolamine—Rash—Methazolamide—glaucoma	0.000274	0.000978	CcSEcCtD
Scopolamine—Dermatitis—Methazolamide—glaucoma	0.000274	0.000978	CcSEcCtD
Scopolamine—Eye disorder—Clonidine—glaucoma	0.000274	0.000977	CcSEcCtD
Scopolamine—Nausea—Carbachol—glaucoma	0.000274	0.000977	CcSEcCtD
Scopolamine—Sweating—Betaxolol—glaucoma	0.000272	0.000972	CcSEcCtD
Scopolamine—Headache—Methazolamide—glaucoma	0.000272	0.000972	CcSEcCtD
Scopolamine—Hypotension—Brimonidine—glaucoma	0.00027	0.000963	CcSEcCtD
Scopolamine—Nausea—Levobunolol—glaucoma	0.00027	0.000962	CcSEcCtD
Scopolamine—Nervous system disorder—Travoprost—glaucoma	0.000269	0.000961	CcSEcCtD
Scopolamine—Tachycardia—Travoprost—glaucoma	0.000268	0.000957	CcSEcCtD
Scopolamine—Somnolence—Acetazolamide—glaucoma	0.000268	0.000955	CcSEcCtD
Scopolamine—Skin disorder—Travoprost—glaucoma	0.000267	0.000952	CcSEcCtD
Scopolamine—Hyperhidrosis—Dorzolamide—glaucoma	0.000267	0.000952	CcSEcCtD
Scopolamine—Abdominal pain—Apraclonidine—glaucoma	0.000266	0.000949	CcSEcCtD
Scopolamine—Nervous system disorder—Brinzolamide—glaucoma	0.000266	0.000949	CcSEcCtD
Scopolamine—Rash—Latanoprost—glaucoma	0.000265	0.000947	CcSEcCtD
Scopolamine—Dermatitis—Latanoprost—glaucoma	0.000265	0.000946	CcSEcCtD
Scopolamine—Tachycardia—Brinzolamide—glaucoma	0.000265	0.000945	CcSEcCtD
Scopolamine—Headache—Latanoprost—glaucoma	0.000264	0.000941	CcSEcCtD
Scopolamine—Skin disorder—Brinzolamide—glaucoma	0.000263	0.00094	CcSEcCtD
Scopolamine—Confusional state—Pilocarpine—glaucoma	0.000263	0.000938	CcSEcCtD
Scopolamine—Arrhythmia—Clonidine—glaucoma	0.000262	0.000934	CcSEcCtD
Scopolamine—Oedema—Pilocarpine—glaucoma	0.000261	0.00093	CcSEcCtD
Scopolamine—Bradycardia—Betaxolol—glaucoma	0.00026	0.000927	CcSEcCtD
Scopolamine—Fatigue—Acetazolamide—glaucoma	0.00026	0.000926	CcSEcCtD
Scopolamine—Nausea—Methazolamide—glaucoma	0.000258	0.000922	CcSEcCtD
Scopolamine—Hypotension—Dorzolamide—glaucoma	0.000258	0.00092	CcSEcCtD
Scopolamine—Somnolence—Brimonidine—glaucoma	0.000257	0.000917	CcSEcCtD
Scopolamine—Mental disorder—Clonidine—glaucoma	0.000257	0.000916	CcSEcCtD
Scopolamine—Hypotension—Travoprost—glaucoma	0.000257	0.000916	CcSEcCtD
Scopolamine—Erythema—Clonidine—glaucoma	0.000255	0.00091	CcSEcCtD
Scopolamine—Tachycardia—Pilocarpine—glaucoma	0.000254	0.000908	CcSEcCtD
Scopolamine—Hallucination—Betaxolol—glaucoma	0.000254	0.000906	CcSEcCtD
Scopolamine—Hypotension—Brinzolamide—glaucoma	0.000253	0.000905	CcSEcCtD
Scopolamine—Pharyngitis—Betaxolol—glaucoma	0.000253	0.000904	CcSEcCtD
Scopolamine—Hyperhidrosis—Pilocarpine—glaucoma	0.000252	0.000899	CcSEcCtD
Scopolamine—Fatigue—Brimonidine—glaucoma	0.000249	0.000889	CcSEcCtD
Scopolamine—Feeling abnormal—Acetazolamide—glaucoma	0.000248	0.000885	CcSEcCtD
Scopolamine—Pain—Brimonidine—glaucoma	0.000247	0.000882	CcSEcCtD
Scopolamine—Visual impairment—Betaxolol—glaucoma	0.000246	0.000877	CcSEcCtD
Scopolamine—Somnolence—Dorzolamide—glaucoma	0.000245	0.000875	CcSEcCtD
Scopolamine—Hypotension—Pilocarpine—glaucoma	0.000244	0.000869	CcSEcCtD
Scopolamine—Dysuria—Timolol—glaucoma	0.000243	0.000869	CcSEcCtD
Scopolamine—Asthenia—Apraclonidine—glaucoma	0.000241	0.000862	CcSEcCtD
Scopolamine—Somnolence—Brinzolamide—glaucoma	0.000241	0.000861	CcSEcCtD
Scopolamine—Vision blurred—Clonidine—glaucoma	0.00024	0.000858	CcSEcCtD
Scopolamine—Tremor—Clonidine—glaucoma	0.000239	0.000853	CcSEcCtD
Scopolamine—Eye disorder—Betaxolol—glaucoma	0.000238	0.000851	CcSEcCtD
Scopolamine—Pruritus—Apraclonidine—glaucoma	0.000238	0.00085	CcSEcCtD
Scopolamine—Body temperature increased—Acetazolamide—glaucoma	0.000238	0.000849	CcSEcCtD
Scopolamine—Fatigue—Dorzolamide—glaucoma	0.000238	0.000849	CcSEcCtD
Scopolamine—Fatigue—Travoprost—glaucoma	0.000237	0.000845	CcSEcCtD
Scopolamine—Flushing—Betaxolol—glaucoma	0.000237	0.000845	CcSEcCtD
Scopolamine—Pain—Dorzolamide—glaucoma	0.000236	0.000842	CcSEcCtD
Scopolamine—Constipation—Travoprost—glaucoma	0.000235	0.000838	CcSEcCtD
Scopolamine—Pain—Travoprost—glaucoma	0.000235	0.000838	CcSEcCtD
Scopolamine—Agitation—Clonidine—glaucoma	0.000234	0.000837	CcSEcCtD
Scopolamine—Asthenia—Bimatoprost—glaucoma	0.000234	0.000835	CcSEcCtD
Scopolamine—Fatigue—Brinzolamide—glaucoma	0.000234	0.000835	CcSEcCtD
Scopolamine—Pain—Brinzolamide—glaucoma	0.000232	0.000828	CcSEcCtD
Scopolamine—Somnolence—Pilocarpine—glaucoma	0.000232	0.000827	CcSEcCtD
Scopolamine—Pruritus—Bimatoprost—glaucoma	0.000231	0.000824	CcSEcCtD
Scopolamine—Arrhythmia—Betaxolol—glaucoma	0.000228	0.000813	CcSEcCtD
Scopolamine—Feeling abnormal—Dorzolamide—glaucoma	0.000227	0.000811	CcSEcCtD
Scopolamine—Feeling abnormal—Travoprost—glaucoma	0.000226	0.000808	CcSEcCtD
Scopolamine—Conjunctivitis—Timolol—glaucoma	0.000226	0.000805	CcSEcCtD
Scopolamine—Feeling abnormal—Brinzolamide—glaucoma	0.000224	0.000798	CcSEcCtD
Scopolamine—Mental disorder—Betaxolol—glaucoma	0.000224	0.000798	CcSEcCtD
Scopolamine—Pain—Pilocarpine—glaucoma	0.000223	0.000796	CcSEcCtD
Scopolamine—Constipation—Pilocarpine—glaucoma	0.000223	0.000796	CcSEcCtD
Scopolamine—Sweating—Timolol—glaucoma	0.000223	0.000794	CcSEcCtD
Scopolamine—Dizziness—Apraclonidine—glaucoma	0.000223	0.000794	CcSEcCtD
Scopolamine—Erythema—Betaxolol—glaucoma	0.000222	0.000793	CcSEcCtD
Scopolamine—Abdominal pain—Dorzolamide—glaucoma	0.000218	0.000778	CcSEcCtD
Scopolamine—Body temperature increased—Dorzolamide—glaucoma	0.000218	0.000778	CcSEcCtD
Scopolamine—Abdominal pain—Travoprost—glaucoma	0.000217	0.000775	CcSEcCtD
Scopolamine—Asthenia—Acetazolamide—glaucoma	0.000216	0.000771	CcSEcCtD
Scopolamine—Dizziness—Bimatoprost—glaucoma	0.000216	0.00077	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000216	0.00077	CcSEcCtD
Scopolamine—Feeling abnormal—Pilocarpine—glaucoma	0.000215	0.000767	CcSEcCtD
Scopolamine—Vomiting—Apraclonidine—glaucoma	0.000214	0.000764	CcSEcCtD
Scopolamine—Dry mouth—Clonidine—glaucoma	0.000212	0.000758	CcSEcCtD
Scopolamine—Bradycardia—Timolol—glaucoma	0.000212	0.000757	CcSEcCtD
Scopolamine—Dermatitis—Apraclonidine—glaucoma	0.000212	0.000756	CcSEcCtD
Scopolamine—Headache—Apraclonidine—glaucoma	0.000211	0.000752	CcSEcCtD
Scopolamine—Confusional state—Clonidine—glaucoma	0.00021	0.000749	CcSEcCtD
Scopolamine—Vision blurred—Betaxolol—glaucoma	0.000209	0.000747	CcSEcCtD
Scopolamine—Oedema—Clonidine—glaucoma	0.000208	0.000743	CcSEcCtD
Scopolamine—Tremor—Betaxolol—glaucoma	0.000208	0.000743	CcSEcCtD
Scopolamine—Hallucination—Timolol—glaucoma	0.000207	0.00074	CcSEcCtD
Scopolamine—Asthenia—Brimonidine—glaucoma	0.000207	0.00074	CcSEcCtD
Scopolamine—Body temperature increased—Pilocarpine—glaucoma	0.000206	0.000735	CcSEcCtD
Scopolamine—Abdominal pain—Pilocarpine—glaucoma	0.000206	0.000735	CcSEcCtD
Scopolamine—Rash—Bimatoprost—glaucoma	0.000206	0.000734	CcSEcCtD
Scopolamine—Dermatitis—Bimatoprost—glaucoma	0.000206	0.000733	CcSEcCtD
Scopolamine—Pruritus—Brimonidine—glaucoma	0.000204	0.000729	CcSEcCtD
Scopolamine—Headache—Bimatoprost—glaucoma	0.000204	0.000729	CcSEcCtD
Scopolamine—Nervous system disorder—Clonidine—glaucoma	0.000204	0.000729	CcSEcCtD
Scopolamine—Tachycardia—Clonidine—glaucoma	0.000203	0.000725	CcSEcCtD
Scopolamine—Skin disorder—Clonidine—glaucoma	0.000202	0.000722	CcSEcCtD
Scopolamine—Hyperhidrosis—Clonidine—glaucoma	0.000201	0.000718	CcSEcCtD
Scopolamine—Visual impairment—Timolol—glaucoma	0.000201	0.000717	CcSEcCtD
Scopolamine—Nausea—Apraclonidine—glaucoma	0.0002	0.000713	CcSEcCtD
Scopolamine—Vertigo—Betaxolol—glaucoma	0.0002	0.000712	CcSEcCtD
Scopolamine—Dizziness—Acetazolamide—glaucoma	0.000199	0.00071	CcSEcCtD
Scopolamine—Asthenia—Dorzolamide—glaucoma	0.000198	0.000706	CcSEcCtD
Scopolamine—Asthenia—Travoprost—glaucoma	0.000197	0.000703	CcSEcCtD
Scopolamine—Pruritus—Dorzolamide—glaucoma	0.000195	0.000697	CcSEcCtD
Scopolamine—Eye disorder—Timolol—glaucoma	0.000195	0.000695	CcSEcCtD
Scopolamine—Asthenia—Brinzolamide—glaucoma	0.000195	0.000695	CcSEcCtD
Scopolamine—Hypotension—Clonidine—glaucoma	0.000195	0.000694	CcSEcCtD
Scopolamine—Pruritus—Travoprost—glaucoma	0.000194	0.000694	CcSEcCtD
Scopolamine—Nausea—Bimatoprost—glaucoma	0.000194	0.000692	CcSEcCtD
Scopolamine—Pruritus—Brinzolamide—glaucoma	0.000192	0.000685	CcSEcCtD
Scopolamine—Vomiting—Acetazolamide—glaucoma	0.000191	0.000683	CcSEcCtD
Scopolamine—Dizziness—Brimonidine—glaucoma	0.000191	0.000682	CcSEcCtD
Scopolamine—Headache—Acetazolamide—glaucoma	0.000189	0.000673	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000188	0.00067	CcSEcCtD
Scopolamine—Asthenia—Pilocarpine—glaucoma	0.000187	0.000668	CcSEcCtD
Scopolamine—Arrhythmia—Timolol—glaucoma	0.000186	0.000664	CcSEcCtD
Scopolamine—Somnolence—Clonidine—glaucoma	0.000185	0.000661	CcSEcCtD
Scopolamine—Dry mouth—Betaxolol—glaucoma	0.000185	0.00066	CcSEcCtD
Scopolamine—Pruritus—Pilocarpine—glaucoma	0.000184	0.000658	CcSEcCtD
Scopolamine—Confusional state—Betaxolol—glaucoma	0.000183	0.000652	CcSEcCtD
Scopolamine—Mental disorder—Timolol—glaucoma	0.000183	0.000652	CcSEcCtD
Scopolamine—Dizziness—Dorzolamide—glaucoma	0.000182	0.000651	CcSEcCtD
Scopolamine—Rash—Brimonidine—glaucoma	0.000182	0.00065	CcSEcCtD
Scopolamine—Dermatitis—Brimonidine—glaucoma	0.000182	0.000649	CcSEcCtD
Scopolamine—Dizziness—Travoprost—glaucoma	0.000182	0.000648	CcSEcCtD
Scopolamine—Erythema—Timolol—glaucoma	0.000181	0.000647	CcSEcCtD
Scopolamine—Oedema—Betaxolol—glaucoma	0.000181	0.000647	CcSEcCtD
Scopolamine—Headache—Brimonidine—glaucoma	0.000181	0.000646	CcSEcCtD
Scopolamine—Fatigue—Clonidine—glaucoma	0.000179	0.000641	CcSEcCtD
Scopolamine—Dizziness—Brinzolamide—glaucoma	0.000179	0.00064	CcSEcCtD
Scopolamine—Nausea—Acetazolamide—glaucoma	0.000179	0.000638	CcSEcCtD
Scopolamine—Constipation—Clonidine—glaucoma	0.000178	0.000635	CcSEcCtD
Scopolamine—Pain—Clonidine—glaucoma	0.000178	0.000635	CcSEcCtD
Scopolamine—Nervous system disorder—Betaxolol—glaucoma	0.000178	0.000634	CcSEcCtD
Scopolamine—Tachycardia—Betaxolol—glaucoma	0.000177	0.000631	CcSEcCtD
Scopolamine—Skin disorder—Betaxolol—glaucoma	0.000176	0.000628	CcSEcCtD
Scopolamine—Vomiting—Dorzolamide—glaucoma	0.000175	0.000626	CcSEcCtD
Scopolamine—Hyperhidrosis—Betaxolol—glaucoma	0.000175	0.000625	CcSEcCtD
Scopolamine—Rash—Dorzolamide—glaucoma	0.000174	0.000621	CcSEcCtD
Scopolamine—Dermatitis—Dorzolamide—glaucoma	0.000174	0.00062	CcSEcCtD
Scopolamine—Rash—Travoprost—glaucoma	0.000173	0.000618	CcSEcCtD
Scopolamine—Dermatitis—Travoprost—glaucoma	0.000173	0.000618	CcSEcCtD
Scopolamine—Headache—Dorzolamide—glaucoma	0.000173	0.000617	CcSEcCtD
Scopolamine—Vomiting—Brinzolamide—glaucoma	0.000172	0.000615	CcSEcCtD
Scopolamine—Dizziness—Pilocarpine—glaucoma	0.000172	0.000615	CcSEcCtD
Scopolamine—Headache—Travoprost—glaucoma	0.000172	0.000614	CcSEcCtD
Scopolamine—Nausea—Brimonidine—glaucoma	0.000172	0.000612	CcSEcCtD
Scopolamine—Feeling abnormal—Clonidine—glaucoma	0.000172	0.000612	CcSEcCtD
Scopolamine—Rash—Brinzolamide—glaucoma	0.000171	0.00061	CcSEcCtD
Scopolamine—Vision blurred—Timolol—glaucoma	0.000171	0.00061	CcSEcCtD
Scopolamine—Dermatitis—Brinzolamide—glaucoma	0.000171	0.00061	CcSEcCtD
Scopolamine—Headache—Brinzolamide—glaucoma	0.00017	0.000606	CcSEcCtD
Scopolamine—Hypotension—Betaxolol—glaucoma	0.000169	0.000604	CcSEcCtD
Scopolamine—Vomiting—Pilocarpine—glaucoma	0.000166	0.000592	CcSEcCtD
Scopolamine—Abdominal pain—Clonidine—glaucoma	0.000165	0.000587	CcSEcCtD
Scopolamine—Body temperature increased—Clonidine—glaucoma	0.000165	0.000587	CcSEcCtD
Scopolamine—Rash—Pilocarpine—glaucoma	0.000164	0.000587	CcSEcCtD
Scopolamine—Dermatitis—Pilocarpine—glaucoma	0.000164	0.000586	CcSEcCtD
Scopolamine—Nausea—Dorzolamide—glaucoma	0.000164	0.000585	CcSEcCtD
Scopolamine—Headache—Pilocarpine—glaucoma	0.000163	0.000583	CcSEcCtD
Scopolamine—Nausea—Travoprost—glaucoma	0.000163	0.000582	CcSEcCtD
Scopolamine—Vertigo—Timolol—glaucoma	0.000163	0.000582	CcSEcCtD
Scopolamine—Nausea—Brinzolamide—glaucoma	0.000161	0.000575	CcSEcCtD
Scopolamine—Fatigue—Betaxolol—glaucoma	0.000156	0.000558	CcSEcCtD
Scopolamine—Constipation—Betaxolol—glaucoma	0.000155	0.000553	CcSEcCtD
Scopolamine—Pain—Betaxolol—glaucoma	0.000155	0.000553	CcSEcCtD
Scopolamine—Nausea—Pilocarpine—glaucoma	0.000155	0.000553	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000153	0.000547	CcSEcCtD
Scopolamine—Dry mouth—Timolol—glaucoma	0.000151	0.000539	CcSEcCtD
Scopolamine—Asthenia—Clonidine—glaucoma	0.000149	0.000533	CcSEcCtD
Scopolamine—Feeling abnormal—Betaxolol—glaucoma	0.000149	0.000533	CcSEcCtD
Scopolamine—Confusional state—Timolol—glaucoma	0.000149	0.000533	CcSEcCtD
Scopolamine—Oedema—Timolol—glaucoma	0.000148	0.000528	CcSEcCtD
Scopolamine—Pruritus—Clonidine—glaucoma	0.000147	0.000526	CcSEcCtD
Scopolamine—Nervous system disorder—Timolol—glaucoma	0.000145	0.000518	CcSEcCtD
Scopolamine—Skin disorder—Timolol—glaucoma	0.000144	0.000513	CcSEcCtD
Scopolamine—Body temperature increased—Betaxolol—glaucoma	0.000143	0.000511	CcSEcCtD
Scopolamine—Hyperhidrosis—Timolol—glaucoma	0.000143	0.000511	CcSEcCtD
Scopolamine—Hypotension—Timolol—glaucoma	0.000138	0.000494	CcSEcCtD
Scopolamine—Dizziness—Clonidine—glaucoma	0.000138	0.000491	CcSEcCtD
Scopolamine—Vomiting—Clonidine—glaucoma	0.000132	0.000472	CcSEcCtD
Scopolamine—Somnolence—Timolol—glaucoma	0.000132	0.00047	CcSEcCtD
Scopolamine—Rash—Clonidine—glaucoma	0.000131	0.000468	CcSEcCtD
Scopolamine—Dermatitis—Clonidine—glaucoma	0.000131	0.000468	CcSEcCtD
Scopolamine—Headache—Clonidine—glaucoma	0.00013	0.000465	CcSEcCtD
Scopolamine—Asthenia—Betaxolol—glaucoma	0.00013	0.000464	CcSEcCtD
Scopolamine—Pruritus—Betaxolol—glaucoma	0.000128	0.000458	CcSEcCtD
Scopolamine—Fatigue—Timolol—glaucoma	0.000128	0.000456	CcSEcCtD
Scopolamine—Pain—Timolol—glaucoma	0.000127	0.000452	CcSEcCtD
Scopolamine—Nausea—Clonidine—glaucoma	0.000124	0.000441	CcSEcCtD
Scopolamine—Feeling abnormal—Timolol—glaucoma	0.000122	0.000435	CcSEcCtD
Scopolamine—Dizziness—Betaxolol—glaucoma	0.00012	0.000428	CcSEcCtD
Scopolamine—Abdominal pain—Timolol—glaucoma	0.000117	0.000418	CcSEcCtD
Scopolamine—Body temperature increased—Timolol—glaucoma	0.000117	0.000418	CcSEcCtD
Scopolamine—Vomiting—Betaxolol—glaucoma	0.000115	0.000411	CcSEcCtD
Scopolamine—Rash—Betaxolol—glaucoma	0.000114	0.000408	CcSEcCtD
Scopolamine—Dermatitis—Betaxolol—glaucoma	0.000114	0.000407	CcSEcCtD
Scopolamine—Headache—Betaxolol—glaucoma	0.000114	0.000405	CcSEcCtD
Scopolamine—Nausea—Betaxolol—glaucoma	0.000108	0.000384	CcSEcCtD
Scopolamine—Asthenia—Timolol—glaucoma	0.000106	0.000379	CcSEcCtD
Scopolamine—Pruritus—Timolol—glaucoma	0.000105	0.000374	CcSEcCtD
Scopolamine—Dizziness—Timolol—glaucoma	9.79e-05	0.000349	CcSEcCtD
Scopolamine—Vomiting—Timolol—glaucoma	9.41e-05	0.000336	CcSEcCtD
Scopolamine—Rash—Timolol—glaucoma	9.34e-05	0.000333	CcSEcCtD
Scopolamine—Dermatitis—Timolol—glaucoma	9.33e-05	0.000333	CcSEcCtD
Scopolamine—Headache—Timolol—glaucoma	9.28e-05	0.000331	CcSEcCtD
Scopolamine—Nausea—Timolol—glaucoma	8.8e-05	0.000314	CcSEcCtD
Scopolamine—CHRM4—G alpha (i) signalling events—C3—glaucoma	4.49e-05	0.00275	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—NTRK1—glaucoma	4.44e-05	0.00272	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—NGF—glaucoma	4.37e-05	0.00268	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—LRP12—glaucoma	4.36e-05	0.00267	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—NR3C1—glaucoma	4.34e-05	0.00266	CbGpPWpGaD
Scopolamine—SI—Disease—BAD—glaucoma	4.24e-05	0.0026	CbGpPWpGaD
Scopolamine—CHRM1—G alpha (q) signalling events—EDN1—glaucoma	4.16e-05	0.00255	CbGpPWpGaD
Scopolamine—CHRM3—G alpha (q) signalling events—EDN1—glaucoma	4.15e-05	0.00254	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.09e-05	0.00251	CbGpPWpGaD
Scopolamine—SI—Metabolism—MTHFR—glaucoma	4.09e-05	0.00251	CbGpPWpGaD
Scopolamine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	4.06e-05	0.00249	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—OPN4—glaucoma	3.96e-05	0.00243	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—OPN4—glaucoma	3.95e-05	0.00242	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	3.93e-05	0.00241	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.92e-05	0.0024	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—OPN4—glaucoma	3.91e-05	0.0024	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—FN1—glaucoma	3.83e-05	0.00235	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—FN1—glaucoma	3.82e-05	0.00234	CbGpPWpGaD
Scopolamine—SI—Metabolism—APOE—glaucoma	3.81e-05	0.00233	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—FN1—glaucoma	3.78e-05	0.00232	CbGpPWpGaD
Scopolamine—SI—Metabolism—CAV1—glaucoma	3.77e-05	0.00231	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	3.75e-05	0.0023	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	3.72e-05	0.00228	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	3.71e-05	0.00227	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—OPN4—glaucoma	3.6e-05	0.00221	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—OPN4—glaucoma	3.59e-05	0.0022	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.57e-05	0.00219	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PTGFR—glaucoma	3.57e-05	0.00219	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PTGFR—glaucoma	3.56e-05	0.00218	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—OPN4—glaucoma	3.55e-05	0.00218	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PTGFR—glaucoma	3.52e-05	0.00216	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—FAS—glaucoma	3.48e-05	0.00213	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.42e-05	0.0021	CbGpPWpGaD
Scopolamine—SI—Disease—NOS3—glaucoma	3.4e-05	0.00209	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PTGFR—glaucoma	3.24e-05	0.00199	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PTGFR—glaucoma	3.23e-05	0.00198	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PTGFR—glaucoma	3.2e-05	0.00196	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—SMO—glaucoma	3.18e-05	0.00195	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—SMO—glaucoma	3.17e-05	0.00195	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—OPN4—glaucoma	3.15e-05	0.00193	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—SMO—glaucoma	3.14e-05	0.00193	CbGpPWpGaD
Scopolamine—SI—Disease—PTGS2—glaucoma	3.11e-05	0.00191	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—EDN1—glaucoma	3.11e-05	0.00191	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LRP12—glaucoma	3.07e-05	0.00188	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CA5A—glaucoma	3.06e-05	0.00188	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NARFL—glaucoma	3.06e-05	0.00188	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LRP12—glaucoma	3.06e-05	0.00187	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LRP12—glaucoma	3.03e-05	0.00186	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—OPN4—glaucoma	3.02e-05	0.00185	CbGpPWpGaD
Scopolamine—CHRM2—G alpha (i) signalling events—C3—glaucoma	2.99e-05	0.00183	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—EDN1—glaucoma	2.98e-05	0.00183	CbGpPWpGaD
Scopolamine—SI—Disease—CDKN1B—glaucoma	2.95e-05	0.00181	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HEYL—glaucoma	2.93e-05	0.0018	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	2.93e-05	0.00179	CbGpPWpGaD
Scopolamine—SI—Metabolism—NOS3—glaucoma	2.85e-05	0.00175	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PTGFR—glaucoma	2.84e-05	0.00174	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HEYL—glaucoma	2.81e-05	0.00172	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.76e-05	0.00169	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.75e-05	0.00168	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.72e-05	0.00167	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—C3—glaucoma	2.72e-05	0.00167	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PTGFR—glaucoma	2.72e-05	0.00167	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	2.7e-05	0.00165	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	2.68e-05	0.00164	CbGpPWpGaD
Scopolamine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	2.66e-05	0.00163	CbGpPWpGaD
Scopolamine—SI—Metabolism—PTGS2—glaucoma	2.61e-05	0.0016	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—C3—glaucoma	2.6e-05	0.0016	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.51e-05	0.00154	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—SMO—glaucoma	2.42e-05	0.00149	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.41e-05	0.00148	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.4e-05	0.00147	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.38e-05	0.00146	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CA1—glaucoma	2.36e-05	0.00144	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—SMO—glaucoma	2.32e-05	0.00142	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—VEGFA—glaucoma	2.3e-05	0.00141	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	2.29e-05	0.00141	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CTSA—glaucoma	2.28e-05	0.0014	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RPTOR—glaucoma	2.22e-05	0.00136	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CA2—glaucoma	2.16e-05	0.00132	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NCK2—glaucoma	2.15e-05	0.00132	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RPTOR—glaucoma	2.13e-05	0.0013	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—OPN4—glaucoma	2.13e-05	0.0013	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—OPN4—glaucoma	2.12e-05	0.0013	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—EDN1—glaucoma	2.1e-05	0.00129	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—OPN4—glaucoma	2.1e-05	0.00129	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—EDN1—glaucoma	2.09e-05	0.00128	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—VEGFA—glaucoma	2.09e-05	0.00128	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—EDN1—glaucoma	2.07e-05	0.00127	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NCK2—glaucoma	2.06e-05	0.00126	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HEYL—glaucoma	1.98e-05	0.00121	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—TNF—glaucoma	1.97e-05	0.00121	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HEYL—glaucoma	1.97e-05	0.00121	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.96e-05	0.0012	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HEYL—glaucoma	1.95e-05	0.0012	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTGFR—glaucoma	1.91e-05	0.00117	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTGFR—glaucoma	1.91e-05	0.00117	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTGFR—glaucoma	1.89e-05	0.00116	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—C3—glaucoma	1.83e-05	0.00112	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.83e-05	0.00112	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HDAC9—glaucoma	1.83e-05	0.00112	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—C3—glaucoma	1.83e-05	0.00112	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—C3—glaucoma	1.81e-05	0.00111	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—TNF—glaucoma	1.79e-05	0.0011	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—EDN1—glaucoma	1.76e-05	0.00108	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HDAC9—glaucoma	1.75e-05	0.00107	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—EDN1—glaucoma	1.68e-05	0.00103	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—SMO—glaucoma	1.63e-05	0.001	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—SMO—glaucoma	1.63e-05	0.000998	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—SMO—glaucoma	1.61e-05	0.000989	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—EDN1—glaucoma	1.6e-05	0.000979	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—C3—glaucoma	1.54e-05	0.000942	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—EDN1—glaucoma	1.53e-05	0.000938	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—TXN—glaucoma	1.52e-05	0.000931	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RPTOR—glaucoma	1.5e-05	0.000918	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CA1—glaucoma	1.5e-05	0.000916	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RPTOR—glaucoma	1.49e-05	0.000915	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RPTOR—glaucoma	1.48e-05	0.000906	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—C3—glaucoma	1.47e-05	0.000902	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NCK2—glaucoma	1.45e-05	0.000889	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CTSA—glaucoma	1.45e-05	0.000888	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NCK2—glaucoma	1.45e-05	0.000886	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.44e-05	0.000884	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NCK2—glaucoma	1.43e-05	0.000878	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SMO—glaucoma	1.43e-05	0.000877	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—C3—glaucoma	1.4e-05	0.000856	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SMO—glaucoma	1.37e-05	0.00084	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CA2—glaucoma	1.37e-05	0.000838	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.37e-05	0.000837	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—C3—glaucoma	1.34e-05	0.000819	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NTRK2—glaucoma	1.31e-05	0.000803	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—TP53—glaucoma	1.3e-05	0.000799	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NTRK2—glaucoma	1.25e-05	0.000769	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HDAC9—glaucoma	1.23e-05	0.000756	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HDAC9—glaucoma	1.23e-05	0.000754	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HDAC9—glaucoma	1.22e-05	0.000746	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—EDN1—glaucoma	1.19e-05	0.000727	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—EDN1—glaucoma	1.18e-05	0.000725	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GSTT1—glaucoma	1.18e-05	0.000722	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—EDN1—glaucoma	1.17e-05	0.000718	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.14e-05	0.000696	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NGFR—glaucoma	1.12e-05	0.000689	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—EDN1—glaucoma	1.08e-05	0.00066	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NGFR—glaucoma	1.08e-05	0.000659	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—EDN1—glaucoma	1.07e-05	0.000658	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NTRK1—glaucoma	1.07e-05	0.000654	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—EDN1—glaucoma	1.06e-05	0.000652	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—C3—glaucoma	1.04e-05	0.000635	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—C3—glaucoma	1.03e-05	0.000633	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—C3—glaucoma	1.02e-05	0.000627	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NTRK1—glaucoma	1.02e-05	0.000627	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CDKN2B—glaucoma	9.84e-06	0.000603	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	9.74e-06	0.000597	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SMO—glaucoma	9.65e-06	0.000592	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—TXN—glaucoma	9.64e-06	0.000591	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SMO—glaucoma	9.62e-06	0.00059	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SMO—glaucoma	9.53e-06	0.000584	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—EDN1—glaucoma	9.44e-06	0.000579	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CDKN2B—glaucoma	9.42e-06	0.000577	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—C3—glaucoma	9.41e-06	0.000577	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—C3—glaucoma	9.38e-06	0.000575	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CYP1B1—glaucoma	9.38e-06	0.000575	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ABCA1—glaucoma	9.38e-06	0.000575	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—C3—glaucoma	9.29e-06	0.000569	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—EDN1—glaucoma	9.04e-06	0.000554	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NTRK2—glaucoma	8.83e-06	0.000541	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NTRK2—glaucoma	8.8e-06	0.000539	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NTRK2—glaucoma	8.72e-06	0.000534	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NGF—glaucoma	8.67e-06	0.000532	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	8.59e-06	0.000526	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NGF—glaucoma	8.31e-06	0.000509	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—C3—glaucoma	8.25e-06	0.000505	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—C3—glaucoma	7.9e-06	0.000484	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—APOE—glaucoma	7.68e-06	0.000471	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CAV1—glaucoma	7.61e-06	0.000466	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NGFR—glaucoma	7.57e-06	0.000464	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NGFR—glaucoma	7.55e-06	0.000463	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GSTM1—glaucoma	7.5e-06	0.00046	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NGFR—glaucoma	7.48e-06	0.000458	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTT1—glaucoma	7.47e-06	0.000458	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—APOE—glaucoma	7.35e-06	0.000451	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CAV1—glaucoma	7.28e-06	0.000446	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—FN1—glaucoma	7.24e-06	0.000444	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NTRK1—glaucoma	7.2e-06	0.000441	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NTRK1—glaucoma	7.17e-06	0.00044	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—BAD—glaucoma	7.15e-06	0.000438	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NTRK1—glaucoma	7.1e-06	0.000435	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—FN1—glaucoma	6.93e-06	0.000425	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—BAD—glaucoma	6.85e-06	0.00042	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CDKN2B—glaucoma	6.63e-06	0.000407	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—MTHFR—glaucoma	6.63e-06	0.000406	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CDKN2B—glaucoma	6.61e-06	0.000405	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CDKN2B—glaucoma	6.55e-06	0.000401	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EDN1—glaucoma	6.36e-06	0.00039	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EDN1—glaucoma	6.34e-06	0.000389	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EDN1—glaucoma	6.28e-06	0.000385	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APOE—glaucoma	6.17e-06	0.000378	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CAV1—glaucoma	6.11e-06	0.000375	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ABCA1—glaucoma	5.95e-06	0.000365	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP1B1—glaucoma	5.95e-06	0.000365	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NGF—glaucoma	5.85e-06	0.000358	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NGF—glaucoma	5.83e-06	0.000357	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NGF—glaucoma	5.77e-06	0.000354	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NOS3—glaucoma	5.75e-06	0.000352	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—C3—glaucoma	5.56e-06	0.000341	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—C3—glaucoma	5.54e-06	0.00034	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NOS3—glaucoma	5.51e-06	0.000338	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—C3—glaucoma	5.49e-06	0.000336	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOE—glaucoma	5.18e-06	0.000317	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOE—glaucoma	5.16e-06	0.000316	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CAV1—glaucoma	5.13e-06	0.000314	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CAV1—glaucoma	5.11e-06	0.000313	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOE—glaucoma	5.11e-06	0.000313	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CAV1—glaucoma	5.06e-06	0.00031	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CDKN1B—glaucoma	4.98e-06	0.000305	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FN1—glaucoma	4.88e-06	0.000299	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FN1—glaucoma	4.87e-06	0.000298	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—BAD—glaucoma	4.82e-06	0.000296	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FN1—glaucoma	4.82e-06	0.000295	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—BAD—glaucoma	4.81e-06	0.000295	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CDKN1B—glaucoma	4.77e-06	0.000292	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—BAD—glaucoma	4.76e-06	0.000292	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTM1—glaucoma	4.76e-06	0.000292	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—NOS3—glaucoma	4.62e-06	0.000283	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MMP9—glaucoma	4.61e-06	0.000283	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MMP9—glaucoma	4.42e-06	0.000271	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PTGS2—glaucoma	4.23e-06	0.000259	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MTHFR—glaucoma	4.21e-06	0.000258	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—VEGFA—glaucoma	4.14e-06	0.000254	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—VEGFA—glaucoma	3.97e-06	0.000243	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOE—glaucoma	3.92e-06	0.00024	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CAV1—glaucoma	3.88e-06	0.000238	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NOS3—glaucoma	3.88e-06	0.000238	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NOS3—glaucoma	3.87e-06	0.000237	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NOS3—glaucoma	3.83e-06	0.000235	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CDKN1B—glaucoma	3.36e-06	0.000206	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CDKN1B—glaucoma	3.35e-06	0.000205	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CDKN1B—glaucoma	3.32e-06	0.000203	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TP53—glaucoma	3.13e-06	0.000192	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MMP9—glaucoma	3.11e-06	0.000191	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MMP9—glaucoma	3.1e-06	0.00019	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MMP9—glaucoma	3.07e-06	0.000188	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TP53—glaucoma	3e-06	0.000184	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NOS3—glaucoma	2.93e-06	0.00018	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—VEGFA—glaucoma	2.79e-06	0.000171	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—VEGFA—glaucoma	2.78e-06	0.000171	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—VEGFA—glaucoma	2.76e-06	0.000169	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTGS2—glaucoma	2.68e-06	0.000164	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TP53—glaucoma	2.11e-06	0.000129	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TP53—glaucoma	2.1e-06	0.000129	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TP53—glaucoma	2.08e-06	0.000128	CbGpPWpGaD
